Stay updated on Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial page
- Check4 days agoChange DetectedNew user-help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the recruitment status now reads 'No longer looking for participants'. The Intervention/Treatment heading punctuation was standardized, and the revision version updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check11 days agoChange Detected- Revision: v3.5.5 replaces the previous Revision: v3.5.4 in the page's revision history, indicating the latest build of the page.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedA new revision entry, v3.5.4, was added to the revision history, replacing the previous v3.5.3; this reflects an update to the page's documentation/metadata.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page’s revision/version indicator was updated from **v3.5.2** to **v3.5.3**, reflecting a change in the site’s interface or backend version rather than the underlying clinical trial information.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check68 days agoChange DetectedUpdates to the Study Record Dates (e.g., 2026-04-06; 2026-03-23) reflect maintenance of the page's history. The core trial information remains unchanged.SummaryDifference0.3%

Stay in the know with updates to Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Adrenocortical Carcinoma Clinical Trial page.